Like doDOC Corp.

closed 3/24/2021 via BNC Analysis

Envision Pharma Group, acquired doDOC Corp.

synopsis: Envision Pharma Group, a leading global technology-enabled scientific communications company, is pleased to announce the acquisition of doDOC Corp., a leader in document collaborative review, editing, and authoring. doDoc was founded by MIT alumni in 2015 in Boston, MA, and with a European base in Coimbra, Portugal.
buyer parent: GHO Capital
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: doDOC Corp.
Founded by MIT alumni in 2015 in Boston, MA, and with a European base in Coimbra, Portugal, doDOC has the mission to transform the way life sciences teams write and review their documents, offering cloud-based software for enterprise documentation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2020 via Company Press Release

Phlexglobal, acquired Cunesoft

synopsis: Phlexglobal, the leading provider of Trial Master File (TMF) software and expert services, has acquired Cunesoft, a European leader in cloud-based regulatory software solutions for the life sciences industry. Cunesoft offers a machine learning powered regulatory compliance software suite for compliant document, data and submission management.
buyer parent: Vitruvian Partners LLP
buyer: Phlexglobal
Phlexglobal is the world-leading specialist provider of electronic Trial Master File (eTMF) systems and services to the life sciences industry. Phlexglobal leverages authoritative TMF technologies and expert services to bring order, stability, and control to their client's Trial Master File. "
target: Cunesoft
Cunesoft is a European leader in cloud-based regulatory software solutions and services for all segments within the life sciences industry. Cunesoft offers a machine learning powered regulatory compliance software suite for compliant document, data and submission management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/19/2022 via BusinessWire

Trinity Life Sciences, acquired D Cube Analytics

synopsis: Trinity Life Sciences, a leader in global life sciences commercialization solutions, has acquired D Cube Analytics. D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more effectively and efficiently.
buyer parent: Parthenon Capital Partners
buyer: Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. "
target: D Cube Analytics
D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more effectively and efficiently.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/13/2019 via BNC Analysis

IQVIA, acquired Linguamatics Limited

synopsis: Health analytics and contract research heavyweight IQvia has acquired bioinformatics company Linguamatics. Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text.
buyer: IQVIA (NYSE:IQV:$10,412.00)
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. "
target: Linguamatics Limited
Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text. They empower their customers to speed up drug development and improve patient outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2018 via BusinessWire

Anju Software, acquired Zephyr Health

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, announced that it has acquired San Francisco-based Zephyr Health, a company that provides comprehensive physician, institution and treatment data for every major disease area.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Zephyr Health
Founded in 2011, Zephyr Health is the leading insights-as-a-service company harnessing the power of global healthcare data for precise and confident product lifecycle performance for biopharmaceutical and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/18/2022 via PR Newswire

Celegence Holdings LLC, acquired Qdossier B.V.

synopsis: Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has announced the acquisition of Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for pharmaceutical products. Dossplorer™ is Qdossier's advanced cloud-based dossier management solution.
buyer: Celegence Holdings LLC
Celegence helps life sciences companies navigate complex global regulatory requirements by providing consulting services and solutions dedicated to regulatory affairs. Celegence supports life science customers in the areas of EU MDR compliance, IVDR compliance, regulatory intelligence, and more. "
target: Qdossier B.V.
Qdossier helps life sciences organizations record and exchange proof of quality, safety, and efficacy of medicinal products. Its team of experts boasts a wealth of experience in regulatory affairs, specializing in right first time eCTD lifecycle management and regulatory information management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/9/2020 via Company Press Release

ZEISS Group, acquired Arivis

synopsis: ZEISS, an international technology enterprise operating in the fields of optics and optoelectronics, has acquired a majority stake in arivis, a biomedical software company in Germany. arivis enables users to visualize and manage multi-dimensional image datasets. Their platform features solutions for imaging, compliance, data management, and more.
buyer: ZEISS Group (:$1,364.13)
ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. The ZEISS Group develops, produces and distributes measuring technology, microscopes, medical technology, eyeglass lenses, camera and cinema lenses, binoculars and more. "
target: Arivis
arivis is a biomedical big image data and compliance software company in Germany. arivis enables users to visualize, analyze, distribute and manage multi-terabyte, multi-dimensional image datasets. Their cloud-based platform features solutions for imaging, compliance, data management, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/14/2019 via PR Newswire

Bruker Corporation, acquired Arxspan

synopsis: Bruker Corporation announced that it has acquired Arxspan LLC, a provider of cloud-based scientific software and workflow solutions. Arxspan is known for its line of cloud-based products for the management of research data under the Arxlab®brand. The company has a focus on serving pharmaceutical and biopharma customers.
buyer: Bruker Corporation (BRKR:$2,417.90)
Bruker provides the best technological solution for each analytical task. Bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. "
target: Arxspan
Arxspan provides cloud-based solutions to meet the scientific data management needs of leading life sciences, chemicals, and scientific companies. Arxspan offers ArxLab, a suite of web-based scientific informatics applications, allowing scientists to record, manage, and share their research data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/13/2017 via PR Newswire

SciBite, acquired FactBio Ltd

synopsis: SciBite, a firm whose technology is revolutionising R&D for pharmaceutical companies across the globe, has acquired Cambridge based FactBio, a leading developer of semantic software for data management and curation for the life sciences.
buyer: SciBite
SciBite offer a complete semantic services platform for life sciences that can be used as a data analytics solution by end users and also as a 'pluggable' component to transform existing IT infrastructures into more scientifically aware systems. "
target: FactBio Ltd
FactBio is a leading developer of semantic software for data management and curation for the life sciences. FactBio builds ontologies and tools for the curation and management of scientific data. The company's focus is on biomedical data, with the potential to apply its tools more widely.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/26/2020 via BusinessWire

Dotmatics, will acquire BioBright LLC

synopsis: UK-based Dotmatics Ltd., a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery, and innovation research, will acquire BioBright LLC, a leader in automating the flow of data from laboratory instruments to a secure cloud.
buyer parent: Scottish Equity Partners
buyer: Dotmatics
UK-based Dotmatics is a scientific informatics software and services company that is driving the automation of laboratory workflows for discovery and innovation research—accelerating the journey towards full digitalization and the Lab of the Future. "
target: BioBright LLC
BioBright's mission is to revolutionize the way biological research is done by building tools that augment the scientist. The company's DarwinSync platform automatically uploads scientific data from any instrument and makes it available for search, analysis, and discovery.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/26/2009 via Company Press Release

IDBS, will acquire InforSense Ltd.

synopsis: IDBS, a leading provider of innovative data management solutions to multinational R&D organizations, announced that it has concluded an unconditional agreement to acquire InforSense Ltd, a company providing award-winning scientific and business intelligence (BI) technologies, in an all-cash transaction.
buyer: IDBS
IDBS is a trusted provider of integrated data management software and service solutions to both the life science and non-life science industries. "
target: InforSense Ltd.
InforSense delivers fast answers to complex questions in business, healthcare and life science. InforSense's next generation business and scientific intelligence solutions provide ROI in days, not months.
price ($mm)
$8.25
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/14/2009 via BusinessWire

Verisk Health, Inc., acquired D2Hawkeye, Inc.

synopsis: ISO has acquired D2Hawkeye®, Inc., a provider of information solutions for the healthcare industry. Solutions from D2Hawkeye include advanced healthcare analytics, data mining, decision support, clinical quality analysis, and risk analysis tools. Terms of the transaction were not disclosed.
buyer parent: Insurance Services Office, Inc.
buyer: Verisk Health, Inc.
Verisk Health leverages healthcare data to help businesses understand their medical and financial risk to better manage costs and clinical outcomes. "
target: D2Hawkeye, Inc.
D2Hawkeye (D2) is the market leader for healthcare data service solutions, including data mining, decision support, clinical quality analysis, and risk analysis tools.
price ($mm)
$52
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/23/2010 via BusinessWire

IMI Health, Inc., acquired BoundaryMedical, Inc.

synopsis: IMI Health (IMI), a health care information company, has acquired Minneapolis-based BoundaryMedical, a leading outcomes measurement software company. Boundary’s Outcome Enterprise™ software complements IMI’s health care business intelligence tools giving both companies’ customers more robust data collection and analysis.
buyer: IMI Health, Inc.
Founded in 1995, IMI Health has evolved from being predominately a healthcare data and Business Intelligence platform provider into a healthcare data solutions company. In 2008 the company was listed on INC Magazine’s 5000 fastest growing companies. "
target: BoundaryMedical, Inc.
BoundaryMedical, Inc. is a leading provider of SaaS-based outcome measurement solutions through its Outcome Enterprise™ platform. BoundaryMedical offers an affordable and easy-to-use tool for outcome measurement projects including studies, registries or routine P4P and CER measurement projects.
price ($mm)
rev ($mm)
$1
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 11/17/2008 via PR Newswire

Clinsys Clinical Research, Inc., purchased ClinicalAnalytics(R) from TrialStat Corporation

synopsis: Jubilant Organosys Ltd. announced that its subsidiary Clinsys Clinical Research, Inc.(R), New Jersey, a global contract research organization (CRO), has acquired TrialStat ClinicalAnalytics(R) from TrialStat(R) for a purchase consideration of CAD 750,000.
buyer parent: Jubilant Organosys Ltd.
buyer: Clinsys Clinical Research, Inc.
Clinsys Clinical Research, Inc.®, a Jubilant Organosys company, is a therapeutically focused clinical research organization. We provide pharmaceutical, biotechnology and medical device companies with a broad range of clinical research services. "
seller: TrialStat Corporation
TrialStat is a technology and services company providing powerful, cost-effective turn-key data capture and management tools for researchers and investigators in health care. TrialStat provides industrial strength data management software solutions to the clinical research community.
price ($mm)
$0.62
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/20/2012 via PR Newswire

MD On-Line, Inc., acquired MD Technologies Inc.

synopsis: MD On-Line, Inc., a leading provider of electronic healthcare solutions that leverage data to improve practice efficiency and industry connectivity, announced that it has acquired MD Technologies Inc., a healthcare technology company based in Baton Rouge, Louisiana.
buyer: MD On-Line, Inc.
MD On-Line Inc. is a leading provider of electronic data interchange (EDI) solutions that facilitate the critical connection between doctors and payers. Its offerings enable electronic data capture and entry, and claim and transactional data submission to payers. "
target: MD Technologies Inc.
MD Technologies Inc. is a proven provider of healthcare technology and service solutions to physician practices. MD Technologies' key product line is Medtopia®Manager, a suite of Internet-based business applications and services designed for the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/11/2022 via BusinessWire

Syntellis Performance Solutions, will acquire Stratasan

synopsis: Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, announced a definitive agreement to acquire Stratasan, an industry leader in advanced healthcare market intelligence and data analytics.
buyer parent: Thoma Bravo, LLC
buyer: Syntellis Performance Solutions
Syntellis Performance Solutions provides innovative enterprise performance management software, data and intelligence solutions for healthcare, higher education and financial institutions. "
target: Stratasan
Stratasan is a nationally recognized provider of data analytics software and services for hospitals, ancillary care centers, and payers, helping them improve the efficiency and effectiveness of strategic growth efforts by delivering advanced market intelligence and data analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/10/2019 via PR Newswire

Healthaxis, Inc., acquired Analytics Partners

synopsis: HealthAxis Group announced the acquisition of Analytics Partners based in Jacksonville, FL. Analytics Partners specializes in analytics solutions such as historical trend analysis, risk assessments, fraud indicators and claims reporting for Healthcare organizations.
buyer: Healthaxis, Inc. (HAXS:$0.00)
HealthAxis Group is simultaneously the most experienced and modern SaaS-based supplier of benefit platform systems. The comprehensive suite offered by HealthAxis helps organizations address compliance, increase administrative efficiency, lower cost, and improve quality. "
target: Analytics Partners
Analytics Partners specializes in analytics solutions such as historical trend analysis, risk assessments, fraud indicators and claims reporting for Healthcare organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/31/2017 via Company Press Release

Summa Equity, acquired Ivbar

synopsis: Summa Equity has acquired IVBAR Institute AB. IVBAR is a Swedish digital health company that has developed a big data analytics platform, ERA Vision, that enables improved management of healthcare through a focus on patient value.
buyer: Summa Equity
Summa Equity was formed in 2016 by partners with a shared vision of building a leading specialised private equity firm in the Nordic lower mid-market, positioned to capture the investment opportunity provided by the thematic megatrends expected to drive growth over the long term. "
target: Ivbar
IVBAR is a Swedish digital health company that has developed a big data analytics platform, ERA Vision, that enables improved management of healthcare through a focus on patient value.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/20/2021 via BusinessWire

HealthStream, Inc., acquired ComplyALIGN

synopsis: HealthStream, a leading provider of workforce and provider solutions for the healthcare industry, has acquired ComplyALIGN, a Chicago-based healthcare technology company. Their comprehensive cloud-based platform is used for publishing, accessing and managing organization's policies, procedures and other internal documents.
buyer: HealthStream, Inc. (HSTM:$258.61)
HealthStream is dedicated to improving patient outcomes through the development of healthcare organizations' people. Their solutions are contracted by healthcare organizations for workforce development, management, credentialing, provider enrollment, performance assessment, and more. "
target: ComplyALIGN
ComplyALIGN (incorporated as ProcessDATA, Ltd.) is a Chicago-based healthcare technology company. Their comprehensive cloud-based platform is used for publishing, accessing and managing organization's policies, procedures and other internal documents.
price ($mm)
$2.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2017 via PR Newswire

Change Healthcare Corporation, acquired Docufill, LLC

synopsis: Change Healthcare has acquired Docufill, LLC, a cloud-based technology that allows providers to use a single shared form across the organization to streamline the otherwise administratively complex and redundant credentialing process.
buyer parent: McKesson Corporation
buyer: Change Healthcare Corporation (CHNG:$196.79)
Change Healthcare is inspiring a better healthcare system. They leverage their software and analytics, network solutions, and technology-enabled services to help them improve efficiency, reduce costs, increase cash flow, and more effectively manage complex workflows. "
target: Docufill, LLC
Docufill, LLC is a cloud-based technology that allows providers to use a single shared form across the organization to streamline the otherwise administratively complex and redundant credentialing process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/24/2021 via BNC Analysis

Envision Pharma Group, acquired doDOC Corp.

synopsis: Envision Pharma Group, a leading global technology-enabled scientific communications company, is pleased to announce the acquisition of doDOC Corp., a leader in document collaborative review, editing, and authoring. doDoc was founded by MIT alumni in 2015 in Boston, MA, and with a European base in Coimbra, Portugal.
buyer parent: GHO Capital
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: doDOC Corp.
Founded by MIT alumni in 2015 in Boston, MA, and with a European base in Coimbra, Portugal, doDOC has the mission to transform the way life sciences teams write and review their documents, offering cloud-based software for enterprise documentation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/24/2021 via BNC Analysis

Envision Pharma Group, acquired doDOC Corp.

synopsis: Envision Pharma Group, a leading global technology-enabled scientific communications company, is pleased to announce the acquisition of doDOC Corp., a leader in document collaborative review, editing, and authoring. doDoc was founded by MIT alumni in 2015 in Boston, MA, and with a European base in Coimbra, Portugal.
buyer parent: GHO Capital
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: doDOC Corp.
Founded by MIT alumni in 2015 in Boston, MA, and with a European base in Coimbra, Portugal, doDOC has the mission to transform the way life sciences teams write and review their documents, offering cloud-based software for enterprise documentation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/11/2020 via BNC Analysis

A Consortium of 4 Buyers acquired Envision Pharma Group

synopsis: GHO Capital, together with Mubadala Investment Company, the Abu Dhabi-based sovereign investor, and including HarbourVest Partners and Northwestern Mutual, acquired the majority stake in Envision from Ardian SAS, a Paris-based global buyout firm. Envision Pharma Group is a global technology and scientific communications.
buyer: Mubadala Investment Company
buyer: HarbourVest Partners, LLC
buyer: GHO Capital
buyer: Northwestern Mutual
GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. Mubadala is a pioneering global investor. HarbourVest is an independent, global private markets asset manager. Northwestern Mutual helps families and businesses achieve financial security. "
target parent: Ardian
target: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/9/2020 via BNC Analysis

Envision Pharma Group, acquired 90Ten

synopsis: Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, a global provider of evidence-based communication services and industry-leading technology solutions. The acquisition of 90TEN extends Envision’s footprint in patient engagement and medical communications with its behavioral science methodology.
buyer parent: Ardian
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: 90Ten
90TEN is a global healthcare communications consultancy that aims to make people healthier and happier through education and communications. The company provides PR, medical communications, and patient advocacy services that use behavioral science methodologies to maximize brand and health outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/13/2016 via PE Hub

Ardian, GHO Capital, acquired Envision Pharma, Inc.

synopsis: Leading middle-market private equity firm, The Halifax Group, announced that it has sold Envision Pharma Group to Ardian and GHO Capital. Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
buyer: Ardian
buyer: GHO Capital
Ardian is an independent private investment company with assets of US$55bn managed or advised in Europe, North America and Asia. Global Healthcare Opportunities, or GHO Capital, was founded in 2014 as a specialist healthcare investment adviser based in London. "
target parent: Halifax Group
target: Envision Pharma, Inc.
Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/19/2013 via BusinessWire

Halifax Group, acquired Envision Pharma, Inc.

synopsis: The Halifax Group, a leading middle-market private equity firm, announced that it has acquired Envision Pharma, Inc. from a subsidiary of Express Scripts Holding Co. Envision is an innovative global technology and scientific communication company focused on the pharmaceutical, biotechnology and medical device industries.
buyer: Halifax Group
The Halifax Group is a private equity firm that invests between $10 and $40 million alongside owners and managers of established, growing and profitable companies that are leaders in their market niche. "
target parent: Express Scripts Inc.
target: Envision Pharma, Inc.
Envision Pharma, founded in 2001, is an innovative global technology and scientific communication company serving pharmaceutical, biotechnology and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2008 via PR Newswire

United BioSource Corporation, acquired Envision Pharma, Inc.

synopsis: United BioSource Corporation acquired Envision Pharma, a leading scientific communications and technology company. With a focus on the pharmaceutical and biotechnology industry, Envision integrates scientific communication services and targeted software applications.
buyer parent: Oak Investment Partners
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: Envision Pharma, Inc.
Envision Pharma is an innovative scientific communications and technology company providing commercially focused, strategically driven scientific and technology solutions to the pharmaceutical, biotechnology and device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/11/2020 via BNC Analysis

A Consortium of 4 Buyers acquired Envision Pharma Group

synopsis: GHO Capital, together with Mubadala Investment Company, the Abu Dhabi-based sovereign investor, and including HarbourVest Partners and Northwestern Mutual, acquired the majority stake in Envision from Ardian SAS, a Paris-based global buyout firm. Envision Pharma Group is a global technology and scientific communications.
buyer: Mubadala Investment Company
buyer: HarbourVest Partners, LLC
buyer: GHO Capital
buyer: Northwestern Mutual
GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. Mubadala is a pioneering global investor. HarbourVest is an independent, global private markets asset manager. Northwestern Mutual helps families and businesses achieve financial security. "
target parent: Ardian
target: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/13/2016 via PE Hub

Ardian, GHO Capital, acquired Envision Pharma, Inc.

synopsis: Leading middle-market private equity firm, The Halifax Group, announced that it has sold Envision Pharma Group to Ardian and GHO Capital. Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
buyer: Ardian
buyer: GHO Capital
Ardian is an independent private investment company with assets of US$55bn managed or advised in Europe, North America and Asia. Global Healthcare Opportunities, or GHO Capital, was founded in 2014 as a specialist healthcare investment adviser based in London. "
target parent: Halifax Group
target: Envision Pharma, Inc.
Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/19/2013 via BusinessWire

Halifax Group, acquired Envision Pharma, Inc.

synopsis: The Halifax Group, a leading middle-market private equity firm, announced that it has acquired Envision Pharma, Inc. from a subsidiary of Express Scripts Holding Co. Envision is an innovative global technology and scientific communication company focused on the pharmaceutical, biotechnology and medical device industries.
buyer: Halifax Group
The Halifax Group is a private equity firm that invests between $10 and $40 million alongside owners and managers of established, growing and profitable companies that are leaders in their market niche. "
target parent: Express Scripts Inc.
target: Envision Pharma, Inc.
Envision Pharma, founded in 2001, is an innovative global technology and scientific communication company serving pharmaceutical, biotechnology and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2008 via PR Newswire

United BioSource Corporation, acquired Envision Pharma, Inc.

synopsis: United BioSource Corporation acquired Envision Pharma, a leading scientific communications and technology company. With a focus on the pharmaceutical and biotechnology industry, Envision integrates scientific communication services and targeted software applications.
buyer parent: Oak Investment Partners
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: Envision Pharma, Inc.
Envision Pharma is an innovative scientific communications and technology company providing commercially focused, strategically driven scientific and technology solutions to the pharmaceutical, biotechnology and device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/30/2019 via BusinessWire

Evidera, will acquire Medimix International

synopsis: Evidera, a business unit of PPD, LLC, and a provider of evidence-based solutions demonstrating the real-world effectiveness and safety of health care products, will acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries.
buyer parent: Carlyle Group
buyer: Evidera
Evidera, a PPD business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of health care products. They help biopharmaceutical, biotechnology and medical device companies generate the evidence needed to optimize the market access. "
target: Medimix International
Medimix International specializes in providing business understanding, real-world evidence insights to the pharmaceutical and medical device industries. Medimix’s primary solution, LiveTracker™, is a cloud-based platform that provides real-time monitoring of clients’ particular therapeutic markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2021 via BusinessWire

Scientist.com, acquired InsideScientific Corporation

synopsis: Scientist.com, the life science industry’s leading R&D marketplace, announced that it has completed the acquisition of InsideScientific, an online educational platform for life science researchers. InsideScientific is an online environment rich with information for life science researchers.
buyer: Scientist.com
Scientist.com is the pharmaceutical industry’s leading AI-powered marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saves time and money, reduces risk, and provides access to the latest innovative tools and technologies. "
target: InsideScientific Corporation
InsideScientific is an online educational platform for life science researchers. InsideScientific is an online environment rich with information for life science researchers. Resources include educational webinars, in-lab workshops and training programs, laboratory protocols, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/17/2009 via PR Newswire

Pharmaceutical Institute, acquired GeneEd, Inc.

synopsis: Pharmaceutical Institute announced that it has acquired e-learning assets from GeneEd, Inc., a company specializing in life science courseware. These assets, including 155 highly advanced e-courses, help expand Pharmaceutical Institute's already extensive library of training resources.
buyer parent: Campbell Alliance Group, Inc.
buyer: Pharmaceutical Institute
Pharmaceutical Institute is a leading provider of specialized training programs for the pharmaceutical and biotech industry. They partner with subject matter experts from Campbell Alliance, the parent company, to develop highly impactful dstance learning solutions for pharma professionals. "
target: GeneEd, Inc.
GeneEd is a provider of life science e-learning content.Two scientists and a retired venture capitalist founded GeneEd in 1997. Dr. Sunil Maulik and Dr. Salil Patel have more than 15 years of industry and teaching experience at Roche Bioscience, Doubletwist and other life science companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/30/2020 via BNC Analysis

ResMed, will acquire Snapworx, LLC

synopsis: ResMed announced that it agreed to acquire SnapWorx, a privately held software company providing patient contact management and workflow optimization for the sleep apnea resupply market. SnapWorx's software platform automates workflow and document retrieval.
buyer: ResMed (RMD:$3,443.76)
ResMed, a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. "
target: Snapworx, LLC
SnapWorx, a privately held software company providing patient contact management and workflow optimization for the sleep apnea resupply market. SnapWorx’s software platform automates workflow and document retrieval.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/4/2021 via BNC Analysis

Vespa Capital, acquired SelectScience

synopsis: Vespa Capital, a UK private equity investor, has acquired SelectScience Limited. Bath based SelectScience was founded by Arif and Louise Butt over 20 years ago and has become one of the world’s leading, independent digital publishers providing reputable science technology and research news and trusted product reviews.
buyer: Vespa Capital
Vespa Capital is an established Private Equity investor in the UK lower mid-market. With over £200m of funds under management, they focus on Management Buy Outs and recapitalisations of privately owned businesses with an Enterprise Value between £10m and £70m. "
target: SelectScience
Bath-based SelectScience was founded by Arif and Louise Butt over 20 years ago and has become one of the world’s leading, independent digital publishers providing reputable science technology and research news and trusted product reviews.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/29/2011 via Market Wire

CompareNetworks, Inc., acquired Russell Publishing LLC

synopsis: CompareNetworks, Inc. announced the acquisition of Russell Publishing LLC, complementing the company's innovative online marketplaces with industry-leading pharmaceutical publications. Russell Publishing's titles include American Pharmaceutical Review, Pharmaceutical Outsourcing and International Drug Discovery.
buyer parent: Alta Communications
buyer: CompareNetworks, Inc.
CompareNetworks operates targeted, online, B2B marketplaces for professionals worldwide. The company integrates online marketplaces, email newsletters, award-winning video, whitepapers and editorial content to bring buyers and sellers together. "
target: Russell Publishing LLC
Russell Publishing LLC, a privately held company founded in 1998 and based in Indianapolis, IN, is one of the leading publishers of life science B2B publications in the world. The company's three titles and websites cover all aspects of the pharmaceutical and biopharmaceutical pipeline.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2010 via BusinessWire

Canon Communications, LLC, acquired Pharmalot

synopsis: Canon Communications LLC, announced that it has acquired Pharmalot. As part of the acquisition, Pharmalot’s founder, Ed Silverman, will join Canon as an Editor at Large in the Pharmaceutical Media Group and will continue as Pharmalot’s Editor.
buyer parent: Spectrum Equity Investors
buyer: Canon Communications, LLC
Canon Communications LLC produces tradeshows and conferences for both U.S. and international markets. Canon also publishes magazines and digital media for medical devices, microelectronics, plastics processing, packaging, and other advanced design and manufacturing markets. "
target: Pharmalot
Pharmalot is an influential blog focused on news and information in the pharmaceutical industry. Pharmalot is written by Ed Silverman, a prize-winning journalist who has covered the pharmaceutical industry for the past 15 years.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/17/2022 via PR Web

Red Nucleus Solutions LLC, acquired Yukon Training

synopsis: Red Nucleus, a premier provider of strategic learning and development, scientific services and advisory, and medical communications solutions exclusively for the life sciences industry, has acquired Yukon Training, a leading provider of online modules, off-the-shelf content, and workshops focused on the biopharma and medical device industries.
buyer parent: The Riverside Company
buyer: Red Nucleus Solutions LLC
Red Nucleus is the premier provider of strategic learning and development, scientific services and advisory, and medical communications solutions exclusively for the life sciences industry. "
target: Yukon Training
Yukon Training is a leading provider of online modules, off-the-shelf content, and workshops focused on the biopharma and medical device industries. Yukon customizes its courses to meet each company’s objectives including live, virtual or licensing options for its blended learning workshops.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2014 via Market Wire

Bio-IT World, acquired OpenHelix, LLC

synopsis: OpenHelix, a provider of online and onsite training on some of the most popular and powerful open-access bioinformatics resources on the web, will join the Cambridge Healthtech Institute as a division of Bio-IT World, a leading source of news and opinion on technology and strategic innovation in the life sciences.
buyer parent: Cambridge Healthtech Institute
buyer: Bio-IT World
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life sciences, healthcare, pharmaceutical and regulatory professionals. "
target: OpenHelix, LLC
OpenHelix, a Washington State company, was founded in 2003 to provide training on what was then a fledgling but quickly growing market of open access web based bioinformatics resources.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/3/2013 via Company Press Release

Thomson Reuters, acquired BioWorld

synopsis: BioWorld and its companion publication Medical Device Daily (MDD) have been acquired by Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals. BioWorld covers news on public companies and hard-to-find information on private companies.
buyer: Thomson Reuters (TRI:$6,348.00)
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. It combines industry expertise with innovative technology to deliver critical information to leading decision makers. "
target parent: Thompson Media Group LLC
target: BioWorld
BioWorld covers news on public companies and hard-to-find information on private companies. This news coverage of the biotechnology industry is 100 percent original and available only at BioWorld.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2006 via Company Press Release

Cambridge Heathtech Institute, acquired Bio-IT World

synopsis: Cambridge Healthtech Institute of Newton today announced the acquisition of Bio-IT World, Inc.’s media and events properties. The flagship publication, Bio-IT World magazine, introduced in March 2002, has grown from a 10-times-per-year publication to include a range of online and event businesses.
buyer: Cambridge Heathtech Institute
Cambridge Healthtech Institute’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US. including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk and the World Pharmaceutical Congress. "
target parent: International Data Group
target: Bio-IT World
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life sciences, healthcare, pharmaceutical and regulatory professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/2/2022 via BNC Analysis

M3.com, acquired MirVracha LCC

synopsis: M3, Japan's largest portal site dedicated to healthcare professionals, has acquired MirVracha, which operates the medical professional website "МирВрача" with over 400,000 medical professional members, equivalent to roughly 60% of all physicians in Russia, and mainly provides marketing support services for pharmaceutical companies.
buyer: M3.com (TSE:2413:$1,724.14)
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries. "
target: MirVracha LCC
MirVracha operates the medical professional website "МирВрача" with over 400,000 medical professional members, equivalent to roughly 60% of all physicians in Russia, and mainly provides marketing support services for pharmaceutical companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/17/2008 via Company Press Release

Decision Resources, Inc., acquired Fingertip Formulary

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced that it acquired Fingertip Formulary, the leading provider of access to and insight into formulary data in the United States.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Fingertip Formulary
Fingertip Formulary offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others, in the United States. Fingertip Formulary offers a variety of unique data and marketing solutions that provide access to and insight into formulary data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/11/2020 via BNC Analysis

Huntsworth PLC, will acquire Nucleus Global

synopsis: Huntsworth, an international healthcare and communications group, will acquire UK-based Nucleus Global, one of the world’s largest medical specialist communications groups. The addition of Nucleus Global to Huntsworth creates one of the largest high science teams in the world to meet the needs of next-generation prescription drug development.
buyer parent: Clayton, Dubilier & Rice, Inc.
buyer: Huntsworth PLC (LSE:HNT:$342.69)
UK-based Huntsworth is an international healthcare and communications group. The Group's principal areas of focus are marketing, medical, and immersive communications services to healthcare clients, which are primarily large and mid-size pharmaceutical and biotech companies. "
target: Nucleus Global
UK-based Nucleus Global is a medical communications group that provides strategic communications, publications planning, experts and patients engagement, scientific events management, medical education, internal communications, trainings, and more for pharmaceutical and biotechnology companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2019 via PR Newswire

Crain Communications, Inc., acquired Genomeweb LLC

synopsis: Crain Communications Inc has acquired GenomeWeb, an online news organization serving the global community of scientists, technology professionals and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics. GenomeWeb was launched in 1997 and has a staff of 30 employees located in New York.
buyer: Crain Communications, Inc.
Crain Communications is a privately held media company that produces trusted and relevant news publications, lead generation, research and data products, digital platforms, custom publishing, and events with uncompromising integrity. "
target: Genomeweb LLC
GenomeWeb is an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like doDOC Corp.


read more

doDOC Corp.

Cunesoft

D Cube Analytics

Linguamatics Limited

Zephyr Health

Qdossier B.V.

Arivis

Arxspan

FactBio Ltd

BioBright LLC

InforSense Ltd.

D2Hawkeye, Inc.

BoundaryMedical, Inc.

TrialStat Corporation

MD Technologies Inc.

Stratasan

Analytics Partners

Ivbar

ComplyALIGN

Docufill, LLC

read more

doDOC Corp.

read more

doDOC Corp.

Envision Pharma Group

90Ten

Envision Pharma, Inc.

Envision Pharma, Inc.

Envision Pharma, Inc.

read more

Envision Pharma Group

Envision Pharma, Inc.

Envision Pharma, Inc.

Envision Pharma, Inc.

Medimix International

InsideScientific Corporation

GeneEd, Inc.

Snapworx, LLC

SelectScience

Russell Publishing LLC

Pharmalot

Yukon Training

OpenHelix, LLC

BioWorld

Bio-IT World

MirVracha LCC

Dymaxium, Inc.

Fingertip Formulary

Nucleus Global

Genomeweb LLC

Geography
Matching Companies
Ticker: HCAT
 
 
 
 
 
 
 
 
Health Catalyst
Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. The company's customers leverage the cloud-based analytics software data platform to make data-informed decisions and realize measurable clinical, financial, and operational improvements.
year
2021
rev ($mm)
$241.93
EBITDA ($mm)
($78.79)
EBIT ($mm)
($113.92)
Net Income ($mm)
Employees
1200
  • drill down
  • watch
Ticker: VEEV
 
 
 
 
 
 
 
 
Veeva Systems
Veeva Systems
Veeva Systems is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence and customer success, Veeva has over 300 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs.
year
2021
rev ($mm)
$1,762.04
EBITDA ($mm)
$511.76
EBIT ($mm)
$484.62
Net Income ($mm)
$433.21
Employees
4506
  • drill down
  • watch
Ticker: MODN
 
 
 
 
 
 
 
 
Model N, Inc.
Model N, Inc.
Model N is the pioneer and leading provider of Revenue Management cloud solutions for the Life Sciences and High Technology industries. Model N helps its customers maximize their revenues by maximizing sell time, revenues per opportunity and number of opportunities.
year
2016
rev ($mm)
$106.97
EBITDA ($mm)
($26.81)
EBIT ($mm)
($32.74)
Net Income ($mm)
Employees
814
  • drill down
  • watch
Ticker: OB:NORDH
 
 
 
 
 
 
 
 
Nordhealth AS
Nordhealth AS
Nordhealth AS is a provider of cloud-based Practice Management Software (PMS). Nordhealth is a pioneer and global leader in providing SaaS-solutions for healthcare practitioners, helping healthcare practitioners, improve care, save time and grow their business.
year
2021
rev ($mm)
$22.23
EBITDA ($mm)
($0.24)
EBIT ($mm)
($4.88)
Net Income ($mm)
Employees
300
  • drill down
  • watch
Ticker: TSXV:PHA
 
 
 
 
 
 
 
 
Premier Health of America Inc.
Premier Health of America Inc.
Premier Health of America is a Canadian Healthtech company that provides a comprehensive range of staffing and outsourced services solutions. Premier Health uses its PSweb platform to lead the healthcare services sector digital transformation to provide patients more accessible care services.
year
2020
rev ($mm)
$24.62
EBITDA ($mm)
$2.53
EBIT ($mm)
$2.36
Net Income ($mm)
$0.49
Employees
0
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2021
rev ($mm)
$1,724.14
EBITDA ($mm)
$657.72
EBIT ($mm)
$604.18
Net Income ($mm)
$581.12
Employees
8249
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: AIM:MED
 
 
 
 
 
 
 
 
MedaPhor
MedaPhor
MedaPhor is a global provider of advanced ultrasound training simulators for medical professionals. Founded in 2004, they have headquarters in Cardiff, UK and San Diego, USA, and our customers are some of the world's leading medical institutions.
year
2017
rev ($mm)
$5.48
EBITDA ($mm)
($2.09)
EBIT ($mm)
($2.82)
Net Income ($mm)
Employees
31
  • drill down
  • watch
Ticker: TSXV:EYC
 
 
 
 
 
 
 
 
Binovi
Binovi
Binovi is a neuro-vision enhancement platform that is designed for vision optimization and the enhancement of cognitive skills related to human performance. Binovi helps improve the lives of the 1 in 4 individuals who suffer from some form of visual impairment besides acuity loss.
year
2020
rev ($mm)
$0.42
EBITDA ($mm)
($4.63)
EBIT ($mm)
($4.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Clarivate plc
Clarivate plc
Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation. Clarivate helps customers discover, protect and commercialize their inventions using its trusted subscription and technology-based solutions coupled with deep domain expertise.
year
2021
rev ($mm)
$1,614.03
EBITDA ($mm)
$542.18
EBIT ($mm)
$84.79
Net Income ($mm)
Employees
8568
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,158.07
EBITDA ($mm)
$194.47
EBIT ($mm)
$120.69
Net Income ($mm)
$74.78
Employees
8079
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2022
rev ($mm)
$339.59
EBITDA ($mm)
($27.37)
EBIT ($mm)
($76.52)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2021
rev ($mm)
$221.66
EBITDA ($mm)
$54.10
EBIT ($mm)
$47.15
Net Income ($mm)
$38.31
Employees
1515
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2021
rev ($mm)
$18.63
EBITDA ($mm)
($21.80)
EBIT ($mm)
($22.10)
Net Income ($mm)
Employees
189
  • drill down
  • watch
Ticker: K:HLYK
 
 
 
 
 
 
 
 
HealthLynked
HealthLynked
HealthLynked provides a solution for both patient members and providers to improve healthcare through the exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare.
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch
Ticker: OTCPK:LFER
 
 
 
 
 
 
 
 
Life on Earth, Inc.
Life on Earth, Inc.
Life on Earth is a cloud enterprise software developer. Life on Earth's mission is to rapidly grow their cloud based software and technology solutions to enable secure, smart, compliant and maintainable enterprise business solutions. The company focuses on fast emerging technologies.
year
2021
rev ($mm)
$0.03
EBITDA ($mm)
($0.64)
EBIT ($mm)
($0.96)
Net Income ($mm)
Employees
9
  • drill down
  • watch